GE HealthCare has unveiled CareIntellect for Oncology, a new cloud-based application designed to integrate multi-modal patient data from different systems into a single view.
The cloud application summarises clinical notes and reports using generative AI (GenAI).
It allows care teams to quickly understand disease progression, flag potential deviations from treatment plans, and help the clinicians determine next steps for proactive interventions.
The new application organises structured and unstructured data, summarises medical histories, supports treatment response assessments, and tracks adherence to treatment protocols.
GE HealthCare said it is the first application within its CareIntellect portfolio of clinical and operational applications for healthcare providers.
The CareIntellect for Oncology application is planned to be commercially launched in the US next year, with plans for expansion into Canada, the UK, and Ireland, in future.
GE HealthCare Global chief science and technology officer Taha Kass-Hout said: “CareIntellect is designed to help providers streamline access to critical patient information and surface key changes since the patient’s last visit.
“By ensuring the provider has the right information at their fingertips, they can spend less time sifting through information and more time helping patients.”
GE HealthCare said that its CareIntellect for Oncology solution rapidly organises multi-modal patient data from different systems to provide a single view of the patient’s treatment journey.
The application prevents the need for care teams to search multiple databases, flags the risk of deviation from the treatment plan, and helps them determine potential next steps to intervene.
In addition, CareIntellect for Oncology helps care teams assess potentially suitable clinical trials by comparing the patient’s health record to trial criteria.
Tampa General Hospital and UT Southwestern Medical Center are adopting CareIntellect for Oncology as early evaluators, with integration already underway.
Tampa General Hospital senior vice president and chief transformation officer Peter Chang said: “Tampa General Hospital is looking forward to evaluating CareIntellect for Oncology to provide our care teams with information to move from analysis to action—including making use of the proactive pathways to inform care progression and clinical trial eligibility information.
“We were impressed by how quickly GE HealthCare was able to design the application to include breast cancer in a matter of weeks.
“We look forward to putting this in the hands of our care teams and using the AI-enabled functionality to help clinicians spend time where it matters most—delivering outstanding patient care.”
In a separate development, GE HealthCare has launched the AI Innovation Lab, a new initiative designed to advance early-concept AI technologies, as part of its broader AI and digital strategy.
The initiative is focused on integrating AI into medical devices, building applications that improve clinical decision-making, and using AI to enhance patient outcomes and operational efficiency.
AI Innovation Lab will focus on the Health Companion project, which uses AI to help doctors make faster, more personalised decisions by simulating a multi-disciplinary medical team.
It will also focus on predicting triple-negative breast cancer recurrence, improving care for mothers and babies, and advancing AI tools to assist radiologists in mammogram screenings.
